RASSF1 and ovarian cancer: In conclusion, hypermethylation of RASSF1A promoter was found to be associated with ovarian cancer according to the meta-analysis, which suggested that the promoter methylation of RASSF1A is a potentially useful biomarker in the carcinogenic process of ovarian cancer.